Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Venous occlusive disease: the latest in current management.

× No keyword cloud information.

5 in total

Review 1. Anti-vascular endothelial growth factor for macular edema secondary to central retinal vein occlusion.

Authors: Tasanee Braithwaite; Afshan A Nanji; Paul B Greenberg
Journal: Cochrane Database Syst Rev Date: 2010-10-06

2. Comparison of anti-vascular endothelial growth factors, laser treatments and a combination of the both for treatment of central retinal vein occlusion.

Authors: Yoav Y Pikkel; Adi Sharabi-Nov; Itzchak Beiran; Joseph Pikkel
Journal: Int J Ophthalmol Date: 2016-03-18 Impact factor: 1.779

Review 3. Anti-vascular endothelial growth factor for macular oedema secondary to central retinal vein occlusion.

Authors: Tasanee Braithwaite; Afshan A Nanji; Kristina Lindsley; Paul B Greenberg
Journal: Cochrane Database Syst Rev Date: 2014-05-01

4. SCORE Study report 3: study design and baseline characteristics.

Authors: Michael S Ip; Neal L Oden; Ingrid U Scott; Paul C VanVeldhuisen; Barbara A Blodi; Maria Figueroa; Andrew Antoszyk; Michael Elman
Journal: Ophthalmology Date: 2009-07-19 Impact factor: 12.079

5. Bevacizumab for CRVO Associated CME: Effect of Timing and Frequency of Injections on Final Visual Outcome.

Authors: Joseph Pikkel; Otzem Chassid; Yumna Busool; Ward Srour; Adi Sharabi-Nov; Itzchak Beiran
Journal: J Ophthalmol Date: 2013-12-29 Impact factor: 1.909

5 in total